Advertisement

Spinal Tech

K2M, a spinal device company, has received 510(k) clearance from the U.S. Food and Drug Administration to market its EVEREST Degenerative Spinal System, according to a company news release.

Advertisement

Johnson & Johnson and Synthes have entered into a definitive agreement, in which Johnson & Johnson will acquire Synthes for $21.3 billion, according to a company news release.

Stryker's President and CEO Stephen P. MacMillan recently discussed the recruitment of global employees, saying new additions to the American workforce aren't stacking up to their international counterparts, according to a Kalamazoo Gazette news report.

Advertisement